1,024 results match your criteria: "Heemstede; Leiden University Medical Center S.C.; Huygens & Versteegh M.V.[Affiliation]"
Sleep Med Rev
December 2024
Stichting Epilepsie Instellingen Nederland (SEIN), Sleep-Wake center, Heemstede, the Netherlands; Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address:
PLoS Negl Trop Dis
September 2024
Tanga Research Centre, National Institute for Medical Research, Tanga, Tanzania.
Epilepsia Open
October 2024
Nuffield Department of Clinical Neurosciences, Oxford Epilepsy Research Group, University of Oxford, Oxford, UK.
Objective: To characterize the experience of people with epilepsy and aligned healthcare workers (HCWs) during the first 18 months of the COVID-19 pandemic and compare experiences in high-income countries (HICs) with non-HICs.
Methods: Separate surveys for people with epilepsy and HCWs were distributed online in April 2020. Responses were collected to September 2021.
Neurol Clin Pract
October 2024
Dayanand Medical College & Hospital (GS), Ludhiana; GB Pant Hospital (DC), New Delhi, India; Western Health Medical School (TW), Melbourne, Australia; Department of Clinical & Experimental Epilepsy (JWS), UCL Queen Square Institute of Neurology, London, United Kingdom; Stichting Epilepsie Instellingen Nederland (SEIN) (JWS), Heemstede, Netherlands; and Department of Neurology (JWS), West China Hospital of Sichuan University, Chengdu, China.
Epilepsia Open
October 2024
London WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.
Value Health
December 2024
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands; Erasmus Center for Health Economics Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands; Stichting Epilepsie Instellingen Nederland, Heemstede, The Netherlands; Huygens & Versteegh, Zwijndrecht, The Netherlands.
Objectives: The Epilepsy Support Dog Evaluation study was commissioned by the Dutch Ministry of Health, Welfare and Sports to inform a reimbursement decision on seizure dogs. The randomized trial found that seizure dogs reduce seizure frequency and improve health-related quality of life of persons with severe refractory epilepsy (PSREs). This article examined the cost-effectiveness (CE) of adding seizure dogs to usual care for PSREs in The Netherlands.
View Article and Find Full Text PDFEpilepsia
October 2024
Department of Residential Care, Epilepsy Centre Kempenhaeghe, Heeze, The Netherlands.
Objective: To describe the characteristics of psychogenic non-epileptic (functional) seizures (PNES) in adults with epilepsy and intellectual disability (ID) and to establish differences and risk factors regarding psychosocial functioning between individuals with and without PNES.
Methods: Adults with ID and epilepsy living in epilepsy care facilities in The Netherlands were screened for PNES by a neurologist. A control group consisting of people with epilepsy and ID, without PNES, was matched according to age, sex, and level of ID.
CNS Drugs
October 2024
Stichting Epilepsie Instellingen Nederland (SEIN), 2103 SW, Heemstede, The Netherlands.
Sudden unexpected death in epilepsy (SUDEP) is responsible for most epilepsy-related deaths. It is mainly related to unwitnessed nocturnal convulsions, either focal to bilateral or generalised tonic-clonic seizures (TCS). Targeted preventive strategies are currently lacking as underlying mechanisms are largely unknown.
View Article and Find Full Text PDFEur J Neurol
December 2024
Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.
Background: Neurobehavioural comorbidities have a detrimental effect on the quality of life of people with epilepsy, yet tracking their impact is challenging as behaviour may vary with seizures and anti-seizure medication (ASM) side effects. Smartphones have the potential to monitor day-to-day neurobehavioural patterns objectively. We present the case of a man in his late twenties with drug-resistant focal epilepsy in whom we ascertained the effects of ASM withdrawal and a convulsive seizure on his touchscreen interactions.
View Article and Find Full Text PDFExp Neurol
October 2024
Epilepsy Centre, Department of Clinical Sciences, Lund University, 221 84 Lund, Sweden. Electronic address:
Collagen VI (Col-VI) is an extracellular matrix protein primarily known for its bridging role in connective tissues that has been suggested to play a neuroprotective role. In the present study we report increased mRNA and protein expression of Col-VI in the hippocampus and cortex at a late stage of epileptogenesis in a post-status epilepticus (SE) model of epilepsy and in brain tissue from patients with epilepsy. We further present a novel finding that exposure of mouse hippocampal slices to Col-VI augments paired-pulse facilitation in Schaffer collateral-CA1 excitatory synapses indicating decreased release probability of glutamate.
View Article and Find Full Text PDFNeuroepidemiology
July 2024
Department of Neurology, West of China Hospital, Sichuan University, Chengdu, China.
Background: Premature mortality is a significant part of the epilepsy burden and may vary across populations, especially between high-income and lower- and middle-income countries. People with epilepsy in China are approximately a fifth of the global population with epilepsy. Previous studies were unlikely to represent the situation in China due to limitations in design, methods, sample size, follow-up time, and other inherent population heterogeneity.
View Article and Find Full Text PDFEpilepsia
September 2024
Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.
Sleep
December 2024
Stichting Epilepsie Instellingen Nederland (SEIN), Sleep-Wake Centre, Heemstede, The Netherlands.
Lancet Glob Health
August 2024
African Population and Health Research Center, Nairobi, Kenya; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; The Centre for Global Epilepsy, University of Oxford, Oxford, UK.
Trop Med Int Health
September 2024
Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 3BG & Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
J Patient Saf
September 2024
Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Objective: The objective of this paper is to assess the diagnostic value of an antithrombotic questionnaire tool compared with the hospital's medical record information tool. The hypothesis of this study was that the antithrombotic questionnaire tool could identify patients with potentially incorrect antithrombotic therapy.
Methods: This cross-sectional study was conducted in eight community pharmacies in the Netherlands.
Cell Rep Med
June 2024
Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address:
ATP-binding cassette (ABC) transporters facilitate the movement of diverse molecules across cellular membranes, including those within the CNS. While most extensively studied in microvascular endothelial cells forming the blood-brain barrier (BBB), other CNS cell types also express these transporters. Importantly, disruptions in the CNS microenvironment during disease can alter transporter expression and function.
View Article and Find Full Text PDFExp Neurol
September 2024
Amsterdam UMC location University of Amsterdam, Dept of (Neuro)pathology, Amsterdam Neuroscience, Meibergdreef 9, Amsterdam, the Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.
Drug-resistant epilepsy patients may benefit from non-pharmacological therapies, such as the ketogenic diet (KD). However, its high fat content poses compliance challenges and metabolic risks. To mitigate this, we developed a novel KD composition with less fat and additional nutrients (citrate, nicotinamide riboside, and omega-3 fatty acids) for ketone-independent neuroprotection.
View Article and Find Full Text PDFEuropace
June 2024
Stichting Epilepsie Instellingen Nederland (SEIN), P.O. Box 540, 2130 AM Heemstede, Netherlands.
Epilepsy Res
August 2024
Department of Clinical Neurophysiology (location Zwolle & Heemstede), Stichting Epilepsie Instellingen Nederland (SEIN), Achterweg 5, Heemstede, SW 2103, the Netherlands; Department of Neurology, Leiden University Medical Centre, Albinusdreef 2, Leiden, RC 2300, the Netherlands; Department of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London WC1N 3BG, United Kingdom. Electronic address:
Purpose: Long-term ambulatory EEG recordings can improve the monitoring of absence epilepsy in children, but signal quality and increased review workload are a concern. We evaluated the feasibility of around-the-ears EEG arrays (cEEGrids) to capture 3-Hz short-lasting and ictal spike-and-wave discharges and assessed the performance of automated detection software in cEEGrids data. We compared patterns of bilateral synchronisation between short-lasting and ictal spike-and-wave discharges.
View Article and Find Full Text PDFQual Life Res
August 2024
Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Sci Rep
May 2024
Department of (Neuro)Pathology, Amsterdam UMC, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
The classic ketogenic diet is an effective treatment option for drug-resistant epilepsy, but its high fat content challenges patient compliance. Optimizing liver ketone production guided by a method comparing substrates for their ketogenic potential may help to reduce the fat content of the diet without loss in ketosis induction. Here, we present a liver cell assay measuring the β-hydroxybutyrate (βHB) yield from fatty acid substrates.
View Article and Find Full Text PDFTrials
May 2024
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Introduction: The standard treatment for patients with focal drug-resistant epilepsy (DRE) who are not eligible for open brain surgery is the continuation of anti-seizure medication (ASM) and neuromodulation. This treatment does not cure epilepsy but only decreases severity. The PRECISION trial offers a non-invasive, possibly curative intervention for these patients, which consist of a single stereotactic radiotherapy (SRT) treatment.
View Article and Find Full Text PDFEur J Paediatr Neurol
July 2024
Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, Rome, Italy.
Neurology
June 2024
From Emma's Children's Hospital (H.K., A.M.V.E.), University of Amsterdam; Advisium (H.K., E.B., A.M.V.E.), 's Heeren Loo Zorggroep, Amersfoort; Department on Aging (M.S.), Netherlands Institute of Mental Health and Addiction (Trimbos Institute), Utrecht; Alzheimer Center Amsterdam (S.V.D.L., Y.P.), Amsterdam University Medical Center; Section Genomics of Neurodegenerative Diseases and Aging (S.V.D.L.), Department of Human Genetics Amsterdam UMC; Intellectual Disability Medicine (D.M.-F.), Department of General Practice, Erasmus MC, University Medical Center Rotterdam; ENCORE Expertise Center for Neurocognitive Disorders and Department of Pediatric Neurology (L.W.T.H., M.C.Y.D.W.), Sophia Children's Hospital, Erasmus MC University Medical Center Rotterdam; Erasmus School of Health Policy & Management (L.W.T.H.), Erasmus University Rotterdam; Department of Clinical Genetics (M.M.H.); Department of Human Genetics (M.M.H.), Amsterdam UMC, University of Amsterdam; Emma Center for Personalized Medicine (M.M.H., A.M.V.E.), Amsterdam University Medical Centers; Department of Psychiatry, Erasmus MC University Medical Center, Rotterdam; Department of Neurology and Alzheimer Center Erasmus MC (E.V.D.B.), Erasmus MC University Medical Center, Rotterdam; Amsterdam Neuroscience (Y.P.), Neurodegeneration; Department of (Neuro)Pathology, Amsterdam Neuroscience (E.A.), Amsterdam UMC, University of Amsterdam; Stichting Epilepsie Instellingen Nederland (SEIN) (E.A.), Heemstede, The Netherlands; The Dalglish Family 22q Clinic (E.B.), University Health Network, Toronto, Canada; and Department of Psychiatry and Neuropsychology (E.B.), Maastricht University, Maastricht University, The Netherlands.
Background And Objectives: Knowledge of young-onset Alzheimer disease in adults with Down syndrome has greatly improved clinical care. However, little is known about dementia in rare genetic neurodevelopmental disorders (RGNDs). In this review, a comprehensive overview is provided of reports on dementia and cognitive/adaptive trajectories in adults with RGNDs.
View Article and Find Full Text PDF